Status:

RECRUITING

ENABLE-HCM - AI-ENabled Echocardiography With Ultrasound Beyond the Echo Lab for Better HCM Imaging and Expanded Access

Lead Sponsor:

UltraSight

Conditions:

Hypertrophic Cardiomyopathy (HCM)

Cardiac Imaging

Eligibility:

All Genders

18+ years

Brief Summary

This study evaluates whether healthcare providers without specialized ultrasound training can use UltraSight's machine learning based Guidance Software to perform limited transthoracic echocardiograph...

Detailed Description

This study is evaluating whether healthcare providers without specialized ultrasound training can use UltraSight's Guidance Software to perform heart ultrasound exams (limited transthoracic echocardio...

Eligibility Criteria

Inclusion

  • Male and female subjects aged 18 years or over at the time of screening.
  • Willing and able to give written informed consent.
  • New York Heart Association (NYHA) Class I to III
  • Eligible to receive or currently receiving CamzyosTM per product labelling.

Exclusion

  • Emergency (non-elective) admission within 24 hours prior to participating in the study.
  • Unable to lie down as required in all the classic positions for standard TTE exam: supine on back/left decubitus.
  • Subjects who had technically difficult exam in the past, due to body habitus, upon investigator's discretion.
  • Subjects with body mass index (BMI) above 40 kg/m2.
  • Subjects experiencing a known or suspected acute cardiac event.
  • Subjects with severe chest wall deformities as per previous medical records and physical examination.
  • Subjects who have undergone pneumonectomy.
  • Subjects whose anatomy does not lend itself to yield diagnosable echocardiography clips (i.e., situs inversus with dextrocardia, single ventricle anatomy due to congenital heart defect, etc.).

Key Trial Info

Start Date :

July 25 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

March 1 2026

Estimated Enrollment :

75 Patients enrolled

Trial Details

Trial ID

NCT07155434

Start Date

July 25 2025

End Date

March 1 2026

Last Update

September 4 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Cleveland Clinic, Cardiovascular Medicine Department

Cleveland, Ohio, United States, 44195

ENABLE-HCM - AI-ENabled Echocardiography With Ultrasound Beyond the Echo Lab for Better HCM Imaging and Expanded Access | DecenTrialz